Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Breast 11Thoracic 7Head & Neck 3Genitourinary 3CNS 3Gynecologic 2Dermatologic 2Sarcoma 1Lymphoid 1

Conditions

Prostatic Neoplasms 3

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diagnostic Imaging × Genitourinary × Clear all
NCT06866782 2025-03-11

RING

Fundacio Puigvert

Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT05228197 2025-01-22

IP6-CHAIROS

Imperial College London

Active not recruiting
750 enrolled
Genitourinary

Prostatic Neoplasms

NCT02177526 2015-11-18

Imaging of High Grade Prostate Cancer

Ottawa Hospital Research Institute

Phase NA Terminated
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡